38 Recruiting Acute Myeloid Leukemia Clinical Trials in California
Explore active acute myeloid leukemia research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Acute Myeloid Leukemia Studies in California
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
📍 Providence Saint Joseph Medical Center/Disney Family Cancer Center — Burbank, California
View Study & Checklist ➔A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
📍 Children's Hospital of Central California — Madera, California
View Study & Checklist ➔Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
📍 City of Hope National Medical Center /ID# 269273 — Duarte, California
View Study & Checklist ➔Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
📍 City of Hope — Duarte, California
View Study & Checklist ➔Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
📍 Loma Linda University Cancer Center — Loma Linda, California
View Study & Checklist ➔Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
📍 University of California Irvine — Brisbane, California
View Study & Checklist ➔Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
📍 City of Hope — Duarte, California
View Study & Checklist ➔Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
📍 City of Hope — Duarte, California
View Study & Checklist ➔Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
📍 UCSF-Fresno — Clovis, California
View Study & Checklist ➔A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
📍 City of Hope National Medical Center /ID# 279568 — Duarte, California
View Study & Checklist ➔A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔A Study of BGB-11417 in Participants With Myeloid Malignancies
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
📍 Lucile Packard Children's Hospital /ID# 276015 — Palo Alto, California
View Study & Checklist ➔Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
📍 US-San Francisco CA-UCSF — San Francisco, California
View Study & Checklist ➔